Envoyer ce communique par e-mail
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
*
Marquer les champs requis
Nom du destinataire:
*
Adresse e-mail du destinataire:
Message:
*
Enter security words: